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Although the existence of epithelial stem cells in the skin has been known for some decades from cell kinetic
studies performed in vivo, attempts to prospectively isolate these cells for further biological characterization have
been made possible relatively recently facilitated by the availability of antibodies that detect cell surface markers
on epidermal cells. Elegant gene marking studies in vivo have provided conﬁrmation of the patterns of epithelial
tissue replacement predicted by classical cell turnover studies. But, the identiﬁcation of candidate epidermal stem
cells ex vivo remains an area of great controversy, requiring the re-evaluation of current experimental approaches
that rely of necessity on predicted epidermal stem cell behavior in culture. Here we review the diverse experimental
approaches utilized to identify keratinocyte stem cells and their underlying assumptions. We conclude that hair
follicles and interfollicular epidermis each have their own self-renewing stem cell populations, contributing to
distinct regions of the epithelium during homeostasis, although this is perturbed during wound healing. The need
for the development of more rigorous assays for stem cell activity is highlighted given our recent observations
using current assays and the discovery of new surface markers that identify putative epidermal stem cells.
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The extensive capacity of the epidermis for cell renewal
in vivo has been demonstrated by their ability to survive,
expand, and generate cultured human epidermal sheets
capable of rescuing patients with full thickness burns covering
up to 98% of their body surface that are maintained for over
a decade (Gallico et al, 1984; Compton et al, 1989). Al-
though these studies demonstrate the immense regenera-
tive capacity of keratinocytes, the stem cells in this tissue
remain uncharacterized. Extensive investigation combining
close histological analyses and elegant in vivo cell kinetic
studies conducted worldwide some 25 y ago firmly estab-
lished that murine interfollicular (IF) epidermis is a highly
organized, stratified tissue with an impressive cell turnover
rate which is ultimately dependent on a minor population of
resident stem cells (Mackenzie, 1970; Allen and Potten,
1974; Potten, 1983; Morris et al, 1985). Thus, mature cells
or squames lost from the skin surface are continuously re-
placed by a carefully orchestrated process of cell prolifer-
ation within the basal layer, which lies adjacent to the
basement membrane. Similar in vivo cell kinetic analysis in
mice subsequently established the presence and role of
epithelial stem cells in cell renewal at other anatomical sites
including the bulge region of the hair follicle (HF), limbus of
the cornea, the basal layer of oral mucosa, and in the base
of small intestinal crypts (reviewed by Miller et al (1993)).
The development of cell culture techniques permitting the
in vitro propagation of epithelial cells was a further critical
step advancing the study of epithelial stem cells (Rheinwald
and Green, 1975) providing the impetus for skin biologists
to identify, isolate and assay epidermal stem cells from
explanted tissue using the experimental approaches and
criteria developed in dissecting and ordering the hemo-
poietic stem and progenitor cell hierarchy as a template.
Although the functional attributes of epithelial stem cells
and hemopoietic stem cells will be different, reflecting their
diverse biological roles in the body, they share many op-
erational characteristics of adult stem cells of all conti-
nuously renewing cell populations: low incidence, low
probability of cycling, slow turnover rate, the ability to
self-renew, and the ability to regenerate and repair tissue in
the steady state and following damage. Thus, colony-form-
ing assays, alone or in combination with fluorescence ac-
tivated cell sorting (FACS), and gene marking combined
with the analysis of tissue regeneration in vitro or in vivo
(Barrandon and Green, 1987; Jones and Watt, 1993; Jones
et al, 1995; Mackenzie, 1997; Kolodka et al, 1998; Li et al,
1998; Tani et al, 2000; Ghazizadeh et al, 2001) have proved
extremely useful in beginning to extend our knowledge of
epidermal stem cells.
As in the hemopoietic system, the continuing challenge
for epithelial stem cell biologists is the development and
refinement of predictive surrogate assays which provide a
measure of stem cell activity in cell populations removed
from their native microenvironment. The controversy cur-
rently hotly debated in scientific forums is almost entirely cen-
tered around the validity of specific molecular markers and
assays employed to identify epidermal stem cells either
in situ or ex vivo, and the validity of assays which purportedly
distinguish stem cells from their more committed progeny.
In the absence of (a) a rigorous epidermal stem cell assay
analogous to bone marrow reconstitution with candidate
Abbreviations: EPU, epidermal proliferative unit; FACS, fluores-
cence activated cell sorting; HF, hair follicle; IF, interfollicular; KSC,
keratinocyte stem cell; LRC, label-retaining cell; PMD, post-mitotic
differentiating; SP, side population; TA, transient-amplifying
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hemopoietic stem cells in lethally irradiated mice; (b) a
unique phenotypic marker repertoire; and (c) recombinant
cytokines that have enabled hemopoietic stem cell biolo-
gists to hierarchically order closely related marrow stem and
progenitor cell populations by in vitro surrogate assays
(Bertoncello and Bradford, 1997), epithelial stem cell biol-
ogists have had to resort to readouts which are largely
based on untested assumptions about the expected prop-
erties and behavior of isolated epidermal or keratinocyte
stem cells (KSC).
Consequently, individual laboratories have favored the
use of different surrogate assays which they feel best
measure the characteristic(s) they regard as their gold-
standard criteria defining a stem cell. These include, colony-
forming efficiency, colony size and morphology, epithelial
regeneration, and long-term proliferative potential in vitro. In
this review, we examine the evidence and assumptions
supporting the various experimental approaches taken to
date in evaluating epidermal stem cell potential in vivo and
in vitro and discuss their limitations.
Evidence Supporting the Presence of Stem
Cells in the IF Epidermis In Vivo
The dorsal epithelium in mice is a complex tissue special-
ized into HF, sebaceous glands, and the IF epithelium, each
characterized by its own distinct program of differentiation.
Recent developments have led to re-examination of the
long-held view put forward by Potten, Mackenzie, Bicken-
bach, and Morris that the IF epidermis is a self-renewing
tissue even in hairy skin. These investigators generated
a vast body of compelling cell kinetic data which dem-
onstrated unequivocally that cell replacement in the IF
epidermis occurs within small packets of self-renewing ep-
idermis termed the epidermal proliferative unit or EPU com-
prising about ten basal cells and their suprabasal progeny
lying directly above them. Three classes of basal keratin-
ocytes have been identified by cell turnover studies and
painstaking spatial analysis in situ.
The long-lived KSC comprise a minor subpopulation
(  1%–10% of basal cells) within the center of the EPU that
are relatively quiescent, and identified as single label-re-
taining cells (LRC), after a prolonged chase period (6–8 wk)
following repeated administration of 3H-Tdr. Short-lived
transient-amplifying (TA) cells (  60% of basal cells) locat-
ed peripherally to the KSC are rapidly proliferating cells that
readily incorporate 3H-Tdr, but are lost from the basal layer
to terminal differentiation within 4–5 d (Mackenzie, 1970;
Potten, 1974; MacKenzie and Bickenbach, 1985; Morris
et al, 1985; Bickenbach et al, 1986; see Miller et al (1993) for
detailed review). A third class of basal post-mitotic differ-
entiating (PMD) keratinocytes located at the edges of the
EPU, exhibit the early stages of keratinization as judged by
morphology and ultrastructure (Christophers, 1971; Allen
and Potten, 1974). These PMD cells retain some contact
with the basement membrane but have a shape suggestive
of their being in the process of migrating out of the basal
layer. They can be visualized as K10-positive ‘‘hand-mirror’’-
shaped cells found in both murine and human epidermis
(Schweizer et al, 1984; Mackenzie et al, 1989; Kaur and Li,
2000).
It is well accepted that these three subsets of murine
basal epidermal cells exist in vivo at specific anatomical
sites, i.e., the IF epidermis of the dorsum, ear, and tail. The
interrelationship of these subsets (i.e., KSC ! TA ! PMD
cells) is also apparent and a reasonable model for cell re-
newal. Thus KSC, defined here as LRC generated in new-
born mice, are long-lived and persist into adulthood,
suggesting that they are permanent residents in these tis-
sues. TA cells have a short lifespan in vivo and are lost to
terminal differentiation within weeks. And, migration studies
tracking the progress of 3H-Tdr-labelled cells from the basal
layer into suprabasal layers, provide strong evidence for the
maturation of TA cells into basal PMD cells, and then ter-
minally differentiating suprabasal cells. Importantly, the sus-
pected progression of KSC ! TA ! PMD cells has recently
been confirmed by elegant gene marking and lineage anal-
ysis studies in two independent laboratories. Thus, cultured
murine and human keratinocytes comprised of a mixture of
b-galactosidase transduced and untransduced cells, trans-
planted in vivo, regenerated a chimeric epithelium with
interspersed columns/EPU of transduced (blue) cells (Mac-
kenzie, 1997; Kolodka et al, 1998), providing strong evi-
dence for the clonal derivation of the epidermis from IF stem
cells as originally proposed by Mackenzie and Potten three
decades ago (Mackenzie, 1970; Allen and Potten, 1974).
Most recently, lineage analysis studies of epithelial cells re-
trovirally marked in situ have provided compelling evidence
supporting the self-sustaining units of epidermal cell re-
newal or EPU even in hairy dorsal skin followed over 33 wk
(Ghazizadeh et al, 2001). These data collectively point to a
central role for resident IF stem cells in homeostatic cell
renewal and the generation of mature keratinocytes for the
lifetime of a mouse in vivo.
Physiological Role of HF Stem Cells
Kinetic studies have revealed the presence of stem cells
visualized as slow-cycling cells/LRC in the bulge region of
HF as well as the limbal region of the cornea and the dorsal
tongue mucosa of adult mice (Bickenbach, 1981; Morris et
al, 1985; Bickenbach et al, 1986; Cotsarelis et al, 1989,
1990; Lavker et al, 1991; see Miller et al (1993) for detailed
review). The central role of the bulge region in cell renewal is
supported by studies of human HF demonstrating that epi-
thelial cells within this region have greater proliferative po-
tential than that of IF epidermal cells in culture (Yang et al,
1993; Rochat et al, 1994). A number of recent observations
have led to the concept that the HF stem cells found in the
bulge region are the ultimate precursors of the IF epidermis
under homeostatic conditions, and further that the IF ep-
idermis regenerating cells can be viewed as TA cells (Lavker
and Sun, 2000; Taylor et al, 2000). Specifically, a number of
exquisite in vivo studies tracking the migration of b-gala-
ctosidase- or BrDU-marked cells out of the bulge region
have demonstrated the unequivocal role of these stem cells
to give rise to all HF cell lineages, the sebaceous gland, and
importantly to those regions of the IF epidermis adjacent to
the HF. Whereas the contribution of follicle-derived cells to
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IF epidermis was seen after implanting marked cells into
wounded skin (Oshima et al, 2001) or in neonatal skin (Taylor
et al, 2000), the work of Ghazizadeh et al (2001) clearly
addressed the contribution of adult follicular cells to the IF
epidermis under physiological conditions, i.e., up to 33-wk
post-wounding. The latter study concurred that IF epider-
mal cells adjacent to HF originated from follicular stem cells.
But importantly, self-sustaining units of epidermal cells not
associated with HF were consistently observed (Ghaziza-
deh et al, 2001). Collectively, these studies demonstrate that
the HF is an important reservoir for emergency repopulation
of the IF epidermis following wounding and in the neonate
as suggested previously (Eisen et al, 1956; Krawczyk, 1971;
Al-Barwari and Potten, 1976; Cotsarelis et al, 1990). Further,
parts of the IF epidermis are clearly derived from the HF
routinely, but there is a class of IF epidermal stem cells that
are capable of self-renewal throughout the lifetime of the
animal, independent of the HF.
Another confounding factor in the HF versus IF stem cell
debate has been the observation that some of the slowest
cycling cells, i.e., LRC, are readily found in the bulge region
and not in the IF epidermis. It is important to bear in mind
that IF stem cells exist as single cells at the center of EPUs
and it is therefore harder to locate these single cells in a sea
of unlabelled cells in randomly cut sections. In contrast, the
follicular stem cells exist in a geographically distinct site in
clusters of slowly cycling cells. Further, in common with the
hemopoietic system (Bradford et al, 1997), it is critical to
note that the epithelial stem cell compartment is a dynamic
population of proliferative cells that cycle at a reasonable
rate, although clearly less frequently than TA cells. Thus, the
numbers of LRC found in any tissue at a given time is likely
to reflect the number of divisions it has undergone since
being labelled, the turnover rate of that tissue, and therefore
the demands on the LRC for cell regeneration. That is to
say, DNA label retention is a dynamic property. A study by
Bickenbach quantitating the steady decline in numbers of
LRC at different rates in different epithelia over time ele-
gantly illustrates this point (Bickenbach et al, 1986). Thus,
LRC have to be evaluated in the context of the time over
which label retention is estimated. The difficulty in finding
LRC in the IF epidermis after 8–10-wk post-labelling then,
can most likely be attributed to the rate at which these cells
have to divide to maintain the epidermis, resulting in a more
rapid loss of label and that they are much harder to find. So,
how slowly does a cell have to cycle to qualify as a stem
cell? The point is that one cannot compete for stem cell
status based on the rate at which a DNA label is retained
because this merely reflects the cellular kinetics of a par-
ticular epithelium. In fact, if a cell retains its DNA label for a
prolonged period of time, such as the single LRC found in
the bulge region a year post-labelling (Morris and Potten,
1999), one could argue that it has contributed little to cell
regeneration.
In Vitro Approaches to Deﬁning
Epithelial Stem Cells
It can be confidently stated that all attempts to study ep-
idermal stem cells in vitro are based on very specific as-
sumptions about the intrinsic properties of stem cells made
by the many investigators who have dared to venture into
this minefield of experimental biology. But it should also be
noted that the context in which stem cells are assayed is an
equally, if not more important determinant of the assay
readout. Not only does the act of removing candidate stem
cells from their microenvironmental niche potentially alter
their behavior, but the failure of surrogate assays to reca-
pitulate the conditions under which stem cells grow and
function in situ exerts artificial proliferative and differentia-
tive pressures on these cells which will irreversibly alter their
properties and influence their fate (Lavker and Sun, 2000).
This philosophy is best encapsulated in the following state-
ment made by Potten: ‘‘Stem cells are defined by virtue of
their functional attributes. This immediately imposes diffi-
culties since in order to identify whether a cell is a stem cell
or not its function has to be tested. This inevitably demands
that the cell must be manipulated experimentally, which
may alter its properties’’ (Potten and Loeffler, 1990). In sup-
port of this, Morris and Potten (1994) have elegantly dem-
onstrated that murine epidermal 3H-Tdr LRC (putative KSC)
can be recruited into proliferation upon placing them into
culture. Thus clearly, stem cells do not remain quiescent
when cultured; however, an unmistakable assumption in
some of the pioneering work in the epidermal stem cell area
is the notion that other subpopulations of keratinocyte pro-
genitors, namely TA cells and differentiating cells, exhibit
similar restricted proliferative potential when explanted
in vitro as they do in vivo. For example, Barrandon and Green
(1987) placed individual human keratinocytes in culture and
could subsequently identify three classes of clonal cells:
holoclones, which gave rise to large, rapidly growing col-
onies; paraclones, which formed small colonies that under-
went terminal differentiation after a few cell divisions; and
meroclones, which gave rise to a mixture of growing and
abortive colonies. These workers concluded that holo-
clones were likely to be founded by KSC and paraclones by
TA cells. Importantly, this interpretation was based on the
assumptions that: (a) TA cells when explanted into culture
would not be able to proliferate extensively in vitro and (b)
analogous to the hemopoietic colonies with high prolifera-
tive potential, the large keratinocyte colonies (holoclones)
must be founded by stem cells. It remains unclear exactly
which class of keratinocyte progenitor is represented by
meroclones. In favor of the interpretation that holoclones
are at least enriched for stem cells is the work from De Luca
and Pellegrini showing that holoclones are capable of ex-
tensive long-term proliferation measured over many weeks
in culture both in skin (Mathor et al, 1996) and in the cornea
(Pellegrini et al, 1999). Importantly, the limbal region of the
cornea known to be enriched for LRC gives rise to holo-
clones, whereas the central cornea does not (Pellegrini et al,
1999).
An equally reasonable interpretation of these observa-
tions could be that holoclones arise from both stem and TA
cells, meroclones arise from more committed TA cells and
that paraclones arise from keratinocytes that have initiated
differentiation. Alternately, it could be argued that dispersing
keratinocytes and placing them in culture perturbs the
system so greatly that their behavior cannot reasonably
be equated to that of any specific keratinocyte progenitor
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in vivo under homeostatic conditions, or as stated by Bar-
randon and Green (1987), ‘‘the relation, if any, between
the clonal types we have described and the multiple cell
types defined by thymidine labelling kinetics remains to
be clarified’’.
Identiﬁcation of Markers for the
Detection of KSC
Watt and colleagues described the first attempt to pro-
spectively define and isolate IF epidermal stem cells using
cell surface markers and FACS techniques, an important
prerequisite for further characterization of these cells that
had best been studied in situ until then. Jones and Watt
(1993) demonstrated that cultured human foreskin keratin-
ocytes expressing high levels of b1 integrin had a higher
colony forming efficiency (CFE) determined over 2 wk in
culture, whereas those keratinocytes with lower levels of b1
integrin exhibited poorer CFE. These studies were extended
to freshly isolated human neonatal keratinocytes, which
demonstrated that cells expressing high levels of b1 integrin
could generate an epithelium when grafted onto mice
(Jones et al, 1995), suggesting that this subpopulation of
basal epidermal cells is enriched for KSC. These workers
noted that one class of keratinocytes expressing low levels
of b1 integrin divided one to five times before undergoing
terminal differentiation in vitro and that this appeared to
correspond with the TA population described in vivo by cell
kinetic studies (Jones and Watt, 1993). This assumption
once again underscores the reasoning that whereas epi-
dermal stem cells are recruited to proliferate when cultured,
TA cells continue to exhibit limited proliferation in vitro. Re-
cent experiments in our laboratory indicate that TA cells (our
definitions of which are described in detail below) and even
keratinocytes that have downregulated integrin expression
and begun to express K10 are capable of extensive prolif-
eration in vitro (Li et al, 1998) and can form an epidermis in
an organotypic culture given the right microenvironment (Li
et al, 2004).
Further work from Watt and colleagues has sought to
localize the epidermal stem cells in vivo using b1 integrin as
a marker (Jones et al, 1995; Jensen et al, 1999). Similarly,
other investigators have attempted to show that K15 and
K19 may be markers of HF stem cells (Michel et al,
1996;Lyle et al, 1998), and that p63 may be a stem cell
marker for the IF epidermis (Pellegrini et al, 2001). In this
context, it is worth discussing the factors that need to be
borne in mind when assigning a stem cell marker. Most
notably, the incidence and location of stem cells has been
well characterized by many groups who have described
LRC. Thus, a correlation with expected numbers of stem
cells and expected sites of stem cell location should be
important validating criteria. The epitopes recognized by a
particular antibody may also influence the observed staining
pattern, as well as the accessibility of epitopes particularly
when looking at cell surface antigens in situ. Without ex-
ception, although many of the purported stem cell markers
react with cells in the appropriate location, they exhibit too
broad a specificity to be considered as stem cell markers.
Estimates of epidermal stem cell numbers from in vivo
studies indicate that they constitute between 1% and 10%
of the basal layer depending on the methodology used
(Potten and Hendry, 1973; Mackenzie and Bickenbach,
1985; Morris et al, 1985; Bickenbach et al, 1986; Morris and
Potten, 1994). Given their observation that approximately
40% of the basal layer in human foreskin exhibits high levels
of b1 integrin in vivo, Jones et al (1995) concluded that not
all basal keratinocytes with this phenotype can be KSC,
although they postulate that stem cells of the foreskin may
exist as clusters of b1 integrin bright cells (Jensen et al,
1999). It is possible that the incidence of stem cells may be
greater in a neonatal epithelium, or that the spatial arrange-
ment in human foreskin is different from that in murine
epidermal tissues.
Combining In Vitro Assays and In Vivo
Approaches to Identify and Isolate
Epidermal Stem Cells for Further
Characterization
Recent work from our laboratory has sought to devise ways
to identify and isolate epidermal KSC based on multiple
criteria combining what is known from cell kinetic studies in
vivo with in vitro assays adopting the FACS approaches
utilized by hemopoietic stem cell biologists. We have sought
to demonstrate that we have selected epidermal stem cells
based on the incidence of the population, cell size, nuclear
to cytoplasmic ratio, in vivo cell kinetic properties, cell cycle
analysis, long-term proliferative output (measured over
80–90 d), localization to an accepted niche in vivo, i.e., the HF
bulge region, and lack of differentiation markers. We have
also ascribed great importance to working with freshly iso-
lated primary epidermal cells suspecting that culturing the
cells first would lead to a change in the very markers that we
would like to assign to stem cells in vivo. For example, in-
tegrins are upregulated during wound healing in vivo (Hertle
et al, 1992) and therefore may well be altered once kera-
tinocytes are dispersed and placed in culture. We elected to
use the a6 integrin and the 10G7 antigen now known to be
the transferrin receptor or CD71 as cell surface markers to
fractionate primary epidermal cells initially from neonatal
foreskin epidermis (Fig 1). High integrin expression serves
well as a marker for basal cells, permitting their separation
from more committed cells that have initiated their program
of differentiation and suprabasal cells that inevitably form a
part of the isolated primary epidermal preparations. We also
selected a6 rather than b1 integrin because the latter is ex-
pressed on non-epithelial cells that are also present in the
primary cell preparations. Although it was not evident to us
at the time, CD71 was a good choice to separate actively
cycling TA cells from quiescent stem cells, given that it is
highly expressed by many proliferating cells (Trowbridge
and Omary, 1981). This is further confirmed by studies in the
hemopoietic system where the actively proliferating com-
mitted progenitors (CD34þCD71high) can be distinguished
from the stem cell compartment (CD34þCD71dim) on the
basis of CD71 expression (Lansdorp and Dragowska, 1993).
Consistent with this work, we were able to distinguish a
minor population of basal keratinocytes that expressed high
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levels of a6 and low levels of CD71 (a6
briCD71dim; Fig 1) in
human epidermis that fulfilled three important stem cell cri-
teria predicted from in vitro cell kinetic studies: (a) low in-
cidence; (b) relative quiescence determined by cell cycle
analysis; and (c) greatest long-term proliferative capacity
in vitro (Li et al, 1998). In contrast, the remaining a6
bri cells
which expressed high levels of CD71 (a6
briCD71bri; Fig 1)
fulfilled criteria predicted of TA cells: (a) high incidence in the
basal layer; (b) actively cycling; and (c) lower long-term
proliferative potential relative to the a6
briCD71dim cells. A
third population of primary human keratinocytes that ex-
pressed low levels of a6 integrin termed a6
dim, was also
consistently observed in cell preparations (Fig 1). These
cells probably represent a mixture of basal and suprabasal
cells that exhibited a limited proliferative potential in vitro,
expressed K10 (Li et al, 1998) and involucrin (Kaur et al,
2000), which we termed PMD cells based on the relatively
low number of cells in this population in S phase (Li et al,
1998). We expected that the candidate stem cell population
would be maintained in culture longer than the TA and PMD
cells given its inherent proliferative potential, but observed
that the lifespan of all three populations was comparable.
We reasoned that critical growth factors or agents required
for self-renewal were missing from the culture conditions,
resulting in terminal differentiation of the stem cells. This is
consistent with the notion that stem cells retain their char-
acteristic features in vivo due to the occupation of a ‘‘stem
cell niche’’ or microenvironment (Schofield, 1978). Thus,
removal from that niche may well result in differentiation
in vitro.
Further verification that the a6
briCD71dim cells were likely
to be epidermal stem cells was obtained by showing an
enrichment for LRC within this phenotypic fraction, and
conversely localizing pulse-labelled cells to the a6
briCD71bri
phenotypic fraction (Tani et al, 2000), isolated from murine
dorsal epidermis. This direct correlation between pheno-
typically distinct populations, their distinct kinetic turnover
rates in vivo and their long-term proliferative output in vitro
represents the first attempt to reconcile stem cells identified
in situ with their behavior in culture. Further confirmation
came from determining the smaller size and higher nuclear:
cytoplasmic ratio of the a6
briCD71dim cells compared with the
a6
briCD71bri cells. In addition, we were able to demonstrate
that the HF bulge region known to contain LRC was
CD71dim whilst expressing high levels of a6 confirming that
the phenotype we had ascribed to epidermal stem cells on
isolated cells could be verified in vivo. These data have
been confirmed by recent studies from the lab of Watt and
Fuchs localizing slow-cycling cells to this region in whole
mounts (Braun et al, 2003) expressing low levels of CD71
(Tumbar et al, 2004). Our results indicate that stem cells of
both the IF and HF epidermis can be identified by the same
phenotype given our study in non-hairy human skin, al-
though we have yet to demonstrate the presence of
CD71dim cells in the IF epidermis. This is a demanding
technical challenge given the spatial arrangement of these
single isolated cells in the epidermis that lowers the prob-
ability of detecting them; however, consistent with this an
abundance of CD71bri cells are readily detected in the epi-
dermis (Tani et al, 2000).
The multiple stem cell characteristics described by us for
both murine and human epidermal a6
briCD71dim cells sum-
marized in Tables I and II represent the broadest definition
encompassed by any candidate epidermal stem cell pop-
ulation, although sustained tissue regenerative capacity
both in vitro and in vivo needs to be examined, an area that
we are actively pursuing. In addition to the criteria we have
published, we have also sought to determine whether ho-
loclones (large colony-forming cells) can be prospectively
identified within the a6
briCD71dim fraction. In several replicate
experiments, comparing the size of colonies formed by
Figure 1
Phenotype assigned to keratinocyte stem cells (KSC), transit-am-
plifying (TA) cells and early differentiating cells (D) derived from
primary neonatal human foreskin epidermis on the basis of two
cell surface markers: a6 integrin and transferrin receptor/CD71.
Functional assays utilized to distinguish these three phenotypically
discrete compartments are summarized in Table I.
Table I. Features of human basal keratinocytes derived from
neonatal foreskin fractionated according to their
cell surface phenotype
a6
briCD71dim KSC a6
briCD71bri TA a6
dim PMD
Short-term CFE
(2 weeks)
þ þ þ þ þ þ þ þ
Long-term
proliferative
output
(12 weeks)
þ þ þ þ þ þ þ
Cell cycle
analysis
(% cells
in SþG2M)
Low High Low
Incidence 4%–7% Majority Variable
Keratin 14
expression
þ þ þ þ þ þ þ þ
Keratin 10
expression
  þ þ
Involucrin
expression
  þ þ
KSC, keratinocyte stem cell; TA, transient amplifying; PMD, post-mi-
totic differentiation.
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a6
briCD71dim and a6
briCD71bri keratinocytes there was no
enrichment for larger colonies in the KSC fraction—rather dif-
ferent size colonies were obtained in both fractions. These
data suggest that holoclones may arise from stem cells and
TA cells; however, it is important to bear in mind that in our
experiments, keratinocytes have been subjected to exten-
sive manipulation (FACS) prior to assessing their colony-
forming ability. Thus a direct comparison with Barrandon’s
work is difficult.
Limitations of the a6
briCD71dim Phenotype
as a Marker for KSC
Whereas the a6
briCD71dim phenotype is a reliable means of
isolating epidermal stem cells from fresh primary skin tis-
sue, it is unsuitable for studying the behavior of stem cells in
situ during carcinogenesis, wound healing, or in culture. As
discussed before, dispersing keratinocytes from their epi-
thelial sheets in vivo and placing them in culture is akin to
wounding the skin. The result of placing keratinocytes in
culture even for a single passage is an upregulation of a6
integrin and CD71. Thus, irrespective of the original phe-
notype of isolated epidermal cells, we have observed up-
regulation of both the a6 integrin and the transferrin
receptor/CD71 soon after placing them in culture. Specif-
ically, cells of the phenotype a6
briCD71dim, a6
briCD71bri, or
a6
dim gain the TA phenotype (a6
briCD71bri) within one passage
in vitro (Fig 2). This is consistent with in vivo studies showing
upregulation of integrins in wound healing (Hertle et al,
1992), and upregulation of the transferrin receptor by
Table II. Features of murine basal keratinocytes derived
from dorsal skin fractionated according to their cell surface
phenotype
a6
briCD71dim KSC a6
briCD71bri TA
3H-Tdr label-
retaining cells
71.95% 12.6%
3H-Tdr pulse
labelled cells
16.24% 69.73%
Cell cycle analysis
(% cells in SþG2M)
Low High
Incidence 8.1% 58.6%
Nuclear:cytoplasmic ratio High Low
Cell size Small Bigger
Localized to hair follicle
bulge region
þ 
Keratin 14 expression þ þ þ þ þ þ
Keratin 10 expression  
KSC, keratinocyte stem cell; TA, transient amplifying.
Figure 2
Keratinocyte stem cells (KSC) do not maintain the a6
briCD71dim
phenotype in culture. Primary human neonatal foreskin keratinocytes
(panel A) were labelled with antibodies to a6 integrin (x-axis; fluorescein
isothiocyanate) and CD71 (y-axis; phycoerthrin) and subjected to flu-
orescence activated cell sorting (FACS) to obtain KSC (a6
briCD71dim),
transit-amplifying (TA) (a6
briCD71bri), and early differentiating (D) (a6
dim)
cells. These fractions were placed in culture for a single passage, har-
vested and their a6/CD71 cell surface phenotype determined by flow
cytometry. The data demonstrate that all fractions of primary keratin-
ocytes (KSC: panel E; TA: panel D; D cells: panel C) and unsorted
keratinocytes (panel B) upregulate expression of both a6 and CD71
following placement in culture, exhibiting the a6
briCD71bri phenotype
characteristic of TA cells.
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cultured keratinocytes (Kaur et al, 1997). The expression of
CD71 can be downregulated in culture as keratinocytes
become confluent and stop proliferating (Kaur et al, 1997).
Thus, the presence of CD71dim cells in cultures is not a
reliable indicator of stem cells in vitro, but could indicate
differentiation. a6
briCD71dim stem cells also become activat-
ed to proliferate in culture and adopt a TA phenotype (Fig 2),
and therefore cannot be distinguished from TA cells. Sim-
ilarly, CD71 expression is upregulated on epithelial cells in
vivo during development and in transformed cells in both
benign and malignant tumors in vivo (Kaur et al, 1997). Thus,
given that CD71 expression is high on proliferating stem
cells and on TA cells, it is impossible to phenotypically dis-
tinguish TA cells from stem cells in many biologically inter-
esting conditions which result in hyperproliferation (cancer,
wound healing, in vitro). Thus, the identification of new
markers that recognize KSC which are not altered by culture
is important for their study in these particular situations, if
indeed such markers exist.
Can Keratinocyte Stem Cells be Identiﬁed by
Differential Dye Efﬂuxing Properties?
The ‘‘diminishing stem-ness spiral model’’ proposed by
Potten and Loeffler (1990) suggests a continuum between
stem cells and TA cells, accompanied by a gradual loss in
self-renewal capacity and increasing probability of differen-
tiation, implying heterogeneity even within the stem cell
fraction. In fact, direct evidence for such a hierarchy within
the murine hemopoietic stem cell compartment has been
provided by recent studies using Hoechst 33342, (Sigma,
St. Louis, Missouri) which resolves a ‘‘side population’’ (SP)
of hemopoietic progenitors, when fluorescence from this
dye is displayed simultaneously at two emission wave-
lengths: i.e., red and blue (Goodell et al, 1996). The SP cells
represent 0.1% of total bone marrow, exhibit cell surface
markers characteristic of stem cells, and are enriched for
in vivo reconstitution activity. Importantly, the SP is a subset
(  10%) of the Sca-1þ /linneg/low fraction enriched for hem-
opoietic stem cells. Subsequently, this hemopoietic SP has
been fractionated into three subsets of Hoechst-dull/
Rhodamine-dull populations (RI, RII, and RIII), which form
a hierarchy of successively less quiescent and less potent
populations, as determined by their long-term repopulating
ability in ablated mice (Bradford et al, 1997). Importantly, SP
populations can be resolved in hemopoietic tissues from
human, rhesus, and miniature swine bone marrow (Goodell
et al, 1997), and from non-hemopoietic tissues including
muscle (Gussoni et al, 1999). These data suggest that this
method which appears to rely on the differential ability of
stem cells to efflux the Hoechst dye, can be applied to
isolate them from various tissues. Dunnwald et al (2001)
have recently reported a modification of the method for
detecting a purified population of murine epidermal stem
cells, apparently combining staining with Hoechst 33342
and propidium iodide, with selection for small cells to iden-
tify LRC. These data suggest that the epidermis does not
contain an SP analogous to those reported in the bone
marrow and muscle; however, it is difficult to reconcile
these data with that of other laboratories using the Hoechst
red versus blue fluorescence emission to define SP cells
as the SP descriptor is exclusively defined by the dye
specificity of membrane efflux pumps and by the unique
spectral characteristics of Hoechst 33342.
Recent work from our laboratory demonstrates that a
Hoechst-dull SP very similar to that reported for hemopoie-
tic and other tissues can be detected in both murine and
human epidermis (Fig 3). We have determined that the SP
cells isolated from the epidermis are of epithelial origin by
cytokeratin staining, and that they are a minor subset of the
a6
briCD71dim compartment of murine dorsal epithelium (Li,
Redvers & Kaur, unpublished data). By analogy with the
hemopoietic system, it is likely that the Hoecsht SP of the
epidermis are the most primitive stem cells of this tissue.
Without functional evidence to support this notion, it re-
mains for the present an attractive hypothesis requiring
experimental validation.
Tissue Regeneration Assays for
Epidermal Stem Cells
Stem cells are ultimately defined by their ability to sustain
life-long production of mature functional tissue cells in the
steady state and following tissue injury. Integral to this def-
inition is the ability of the stem cell pool to undergo con-
tinuous renewal, regeneration and expansion on demand.
The hemopoietic system is arguably the most instructive
model for the development of cell-separative strategies and
surrogate assays for the prospective isolation and charac-
terization of stem and progenitor cell cohorts of defined
potentiality and differentiative capacity.
The refinement of cell separative strategies for the pro-
spective isolation of hemopoietic stem cells by an iterative
Figure3
Hoechst 33342 staining reveals an epidermal side population (SP)
in adult murine tail keratinocytes. A typical Hoechst red versus blue
fluorescence profile of basal keratinocytes harvested from 9-wk mouse
tail epidermis (stained with 15 mM Hoechst 33342 for 90 min at 371C)
demonstrating the detection of an SP (boxed region) that typically rep-
resent 0.3%–0.5% of total primary keratinocytes isolated from murine
adult tail epidermis.
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process of correlating phenotypic marker expression in
target cells co-fractionating with transplantable stem cell
activity in vivo, and/or surrogate assay readouts in vitro has
revealed that more primitive stem and progenitor cells re-
quire multiple cytokines acting in synergy, often in the pres-
ence of a supportive stromal microenvironment in order to
express their developmental potential in vitro. This notwith-
standing, it has become evident that in vitro surrogate as-
says are imperfect predictive tools for dissecting the stem
cell compartment. Significantly, transplantation is the only
definitive gold-standard assay which identifies the primo-
genitive stem cell pool. This process has provided inves-
tigators with a hierarchy of assays (Fig 4) that not only
resolve stem cells and TA progenitor cells of more restricted
potential, but also enable us to discern a hierarchy of
engraftable cells with differing proliferative capacity and
potentiality within the stem cell compartment which are re-
sponsible for long- and short-term engraftment following
transplantation.
Although much attention has been focussed on clono-
genic assays to determine stem cell activity, tissue regen-
eration from candidate epidermal stem cells isolated
prospectively has not been studied extensively, although
Jones et al (1995) have reported on the ability of b1 integrin
bright keratinocytes to reform an epidermis in vivo following
transplantation. The underlying assumption in this study
was that the ability to regenerate an epidermis was limited
to stem-cell-enriched fractions of basal keratinocytes and
these workers did not compare the relative tissue regener-
ative ability of b1
bri cells with non-stem-cell-enriched frac-
tions. Recent data from our laboratory indicate a strong
need to re-evaluate this assumption and take stock of cur-
rent experimental approaches utilized to determine stem
cell activity. We have found that short-term tissue regener-
ation in organotypic cultures is a function of both (i) the
intrinsic capabilities of the keratinocyte progenitors being
assayed and (ii) extrinsic factors in the microenvironment
included in the assay such as dermally derived growth fac-
tors and extracellular matrix components (Li et al, 2004).
Surprisingly, we could demonstrate that the ability to reform
an epidermis is not an exclusive property of the epidermal
stem cell fraction, but can also be elicited from the TA and
even the PMD population which have initiated differentia-
tion, when provided with the right signals. These data high-
light the value of comparing all fractions of cells so as to
ascertain the suitability of current assay systems to truly
distinguish stem cells from their more committed progeny. It
further points to the strong regulatory role of the micro-
environment in influencing the outcome of the experiment. It
has previously been demonstrated by many investigators
that transplantation of epidermal cells results in improved
keratinocyte growth and differentiation over the organotypic
model, and that transplanted human keratinocytes can be
maintained in mice for periods of up to a year (Kolodka et al,
1998).
On the basis of these findings, and informed by the un-
derstanding gained from the analysis of the hemopoietic
system, we propose that current assays used to evaluate
epidermal stem cell potential are inadequate for distin-
guishing stem cells from their more committed progeny, and
that measurement of stem cell activity requires the devel-
opment of long-term assays that measure sustained epi-
thelial tissue regeneration. In this context, we have chosen
to develop an in vivo transplantation model for human ker-
atinocytes that will permit comparative analysis of keratin-
ocyte progenitors including but not restricted to stem cells.
This assay has been optimized to permit the analysis of
small numbers of primary FACS-isolated human and murine
keratinocytes and can also be utilized to study the com-
petitive repopulation ability of specific classes of genetically
tagged keratinocyte progenitors to establish the potency of
KSC versus TA versus PMD cells (Pouliot et al, submitted).
In conclusion, given that the field of epidermal stem cell
biology is in its infancy, no single parameter is sufficient to
designate a particular subset of cells as stem cells—rather
the collective attributes of quiescence, low incidence, sus-
tained and actual (as opposed to potential) proliferative
output and tissue-regenerative capacity are essential. Thus,
vital steps in the complete biological characterization of
KSC encompass the ability to isolate these cells, propagate
them in vitro and determine their proliferative and tissue-
regenerative potential in various in vitro and in vivo assays.
The establishment of transplantation assays is critical to
understanding the full capability of not just the stem cell
compartment, but also their progeny which may well turn
out to have greater proliferative and tissue regenerative ca-
pacity than previously suspected. In this context, Schneider
et al (2003) have recently reported a transplantation tech-
nique that provides an excellent means to assess the com-
petitive repopulation ability of putative KSC. In particular,
when we venture collectively into ex vivo isolation and ma-
nipulation of epithelial stem cells, it is critical to note that
Figure 4
Schematic representation of the hierarchical organization of hem-
opoietic stem and progenitor cell compartments. The hemopoietic
system comprises a concatenated series of primitive cells of progres-
sively restricted potentiality and proliferative capacity which can be
resolved and characterized using a panel of specific surrogate in vivo
and in vitro functional assays (Bertoncello and Bradford, 1997). LTRA,
transplantable stem cells with long-term reconstituting ability in vivo;
LTCIC, long-term culture initiating cell; CFU-S8 and CFU-S12, colony-
forming unit-spleen measured 8 or 12 d post-transplantation; HPP-
CFC1 and HPP-CFC2, high-proliferative potential colony-forming cells
stimulated by IL1aþ IL3þCSF-1 and IL3þCSF-1, respectively; CFU-
GEMM, colony-forming unit-granulocyte/erythrocyte/macrophage/me-
gakaryocyte; CFU-GM, colony-forming unit-granulocyte/macrophage;
BFU-E, burst-forming unit-erythroid; CFU-E, colony-forming unit-er-
ythroid; LPP-CFC, low proliferative potential colony-forming cell.
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dispersing epithelial cells and placing them into culture is an
exercise in wound healing illustrated by dramatic changes
in gene expression. In this context, our observations that all
classes of basal keratinocytes (KSC, TA, and PMD) exhibit
extensive growth potential in vitro (Li et al, 1998, 2004)
suggest that keratinocyte progenitors may retain more flex-
ibility to revert to a proliferative state when called upon. In
this respect, skin cells may be intrinsically programmed
to retain extensive growth capacity in order to fulfill their
overriding function to cover the body and provide barrier
function.
The arguments about the dependence of the IF epider-
mis on HF stem cells are fuelled by the demonstration that
HF stem cells can give rise to the former. But it is equally
clear that self-renewing stem cells exist in the IF epidermis.
Notably, genetically knocking out b-catenin has been shown
to impair HF stem cell differentiation, ablating HF formation
in these mice (Huelsken et al, 2001). Interestingly, the IF
epidermis in these mice remains normal suggesting that in
the absence of HF, the epidermis is capable of self-renewal.
Conversely over-expressing b-catenin in skin gives rise to
de novo HF formation (Gat et al, 1998) providing insight into
the regulation of fate specification of epidermal progenitors.
It is quite possible that the biology of skin has evolved such
that barrier function is more important than hair growth—
that is to say, we can do without our hair, but not our skin.
The microenvironment in which KSC reside needs to
be defined and the role of specific elements: dermal
cells, growth factors, extracellular matrix components, etc.,
in maintaining stem cells in an undifferentiated state, yet
allowing their neighbors to progress through multiple rounds
of proliferation and terminal differentiation, is a major un-
answered question in stem cell biology.
DOI: 10.1111/j.1087-0024.2004.09306.x
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